TNFα-induced cardioprotection is independent of the activation of the prosurvival kinase Erk

Introduction: Tumour Necrosis Factor alpha (TNFα) contributes to cardiac dysfunction following ischaemia-reperfusion. Nonetheless, brief exposure to exogenous low doses of TNFα can mimic ischaemic preconditioning and thus be cardio-protective. The extracellular signal-regulated kinase (Erk) has been...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sarin Somers, Aurelien Engerer, Sandrine Lecour
Formato: article
Lenguaje:EN
Publicado: South African Heart Association 2017
Materias:
Acceso en línea:https://doaj.org/article/84d0d950263a4a23b28975884a299afd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:84d0d950263a4a23b28975884a299afd
record_format dspace
spelling oai:doaj.org-article:84d0d950263a4a23b28975884a299afd2021-11-22T08:43:05ZTNFα-induced cardioprotection is independent of the activation of the prosurvival kinase Erk10.24170/6-3-19861996-67412071-4602https://doaj.org/article/84d0d950263a4a23b28975884a299afd2017-04-01T00:00:00Zhttps://www.journals.ac.za/index.php/SAHJ/article/view/1986https://doaj.org/toc/1996-6741https://doaj.org/toc/2071-4602Introduction: Tumour Necrosis Factor alpha (TNFα) contributes to cardiac dysfunction following ischaemia-reperfusion. Nonetheless, brief exposure to exogenous low doses of TNFα can mimic ischaemic preconditioning and thus be cardio-protective. The extracellular signal-regulated kinase (Erk) has been implicated in the protection against ischaemia-reperfusion and is known to be activated by TNFα. However, whether Erk activation contributes to TNFα-induced cardio-protection remains unknown. Methods: PD 98059 (10μM), an Erk inhibitor, was used to evaluate the role of this prosurvival kinase with respect to infarct size (expressed as a percentage of the area at risk) in isolated rat hearts subjected to ischaemic preconditioning (IPC) or TNFα preconditioning (TNFαP). Western blot analyses were used to determine the degree of Erk phosphorylation after the application of the preconditioning stimulus. Results: Pre-treatment of the hearts with 0.5ng/ml of TNFα (for 7min) or 2 cycles of 5min ischaemia-reperfusion prior to 30min regional index ischaemia and 2h of reperfusion reduced the infarct size by 76% and 88%, respectively, versus control. Western blot analysis of isolated rat hearts revealed that IPC but not TNFαP activated phosphorylation of Erk (+54% for IPC vs. control). Coadministration of PD 98059 during the preconditioning stimulus did not influence the infarct size. Conclusion: These findings confirm that activation of TNFα may be considered as a novel therapeutic approach against ischaemic heart disease and that its effect is independent of the activation of the classic prosurvival factor Erk.Sarin SomersAurelien EngererSandrine LecourSouth African Heart Associationarticletumour necrosis factor alpha (tnfα)extracellular signal-regulated kinase (erk)ischaemic preconditioningDiseases of the circulatory (Cardiovascular) systemRC666-701ENSA Heart Journal, Vol 6, Iss 3, Pp 168-172 (2017)
institution DOAJ
collection DOAJ
language EN
topic tumour necrosis factor alpha (tnfα)
extracellular signal-regulated kinase (erk)
ischaemic preconditioning
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle tumour necrosis factor alpha (tnfα)
extracellular signal-regulated kinase (erk)
ischaemic preconditioning
Diseases of the circulatory (Cardiovascular) system
RC666-701
Sarin Somers
Aurelien Engerer
Sandrine Lecour
TNFα-induced cardioprotection is independent of the activation of the prosurvival kinase Erk
description Introduction: Tumour Necrosis Factor alpha (TNFα) contributes to cardiac dysfunction following ischaemia-reperfusion. Nonetheless, brief exposure to exogenous low doses of TNFα can mimic ischaemic preconditioning and thus be cardio-protective. The extracellular signal-regulated kinase (Erk) has been implicated in the protection against ischaemia-reperfusion and is known to be activated by TNFα. However, whether Erk activation contributes to TNFα-induced cardio-protection remains unknown. Methods: PD 98059 (10μM), an Erk inhibitor, was used to evaluate the role of this prosurvival kinase with respect to infarct size (expressed as a percentage of the area at risk) in isolated rat hearts subjected to ischaemic preconditioning (IPC) or TNFα preconditioning (TNFαP). Western blot analyses were used to determine the degree of Erk phosphorylation after the application of the preconditioning stimulus. Results: Pre-treatment of the hearts with 0.5ng/ml of TNFα (for 7min) or 2 cycles of 5min ischaemia-reperfusion prior to 30min regional index ischaemia and 2h of reperfusion reduced the infarct size by 76% and 88%, respectively, versus control. Western blot analysis of isolated rat hearts revealed that IPC but not TNFαP activated phosphorylation of Erk (+54% for IPC vs. control). Coadministration of PD 98059 during the preconditioning stimulus did not influence the infarct size. Conclusion: These findings confirm that activation of TNFα may be considered as a novel therapeutic approach against ischaemic heart disease and that its effect is independent of the activation of the classic prosurvival factor Erk.
format article
author Sarin Somers
Aurelien Engerer
Sandrine Lecour
author_facet Sarin Somers
Aurelien Engerer
Sandrine Lecour
author_sort Sarin Somers
title TNFα-induced cardioprotection is independent of the activation of the prosurvival kinase Erk
title_short TNFα-induced cardioprotection is independent of the activation of the prosurvival kinase Erk
title_full TNFα-induced cardioprotection is independent of the activation of the prosurvival kinase Erk
title_fullStr TNFα-induced cardioprotection is independent of the activation of the prosurvival kinase Erk
title_full_unstemmed TNFα-induced cardioprotection is independent of the activation of the prosurvival kinase Erk
title_sort tnfα-induced cardioprotection is independent of the activation of the prosurvival kinase erk
publisher South African Heart Association
publishDate 2017
url https://doaj.org/article/84d0d950263a4a23b28975884a299afd
work_keys_str_mv AT sarinsomers tnfainducedcardioprotectionisindependentoftheactivationoftheprosurvivalkinaseerk
AT aurelienengerer tnfainducedcardioprotectionisindependentoftheactivationoftheprosurvivalkinaseerk
AT sandrinelecour tnfainducedcardioprotectionisindependentoftheactivationoftheprosurvivalkinaseerk
_version_ 1718417807136260096